Overview

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of a particular combination of drugs used to treat cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago
Treatments:
Cytarabine
Etoposide
Etoposide phosphate
Mitoxantrone